Analysis of the secondary structure of the human immunodeficiency virus (HIV) proteins p17, gp120, and gp41 by computer modeling based on neural network methods

J Acquir Immune Defic Syndr (1988). 1990;3(6):615-22.

Abstract

A neural network computer program, trained to predict secondary structure of proteins by exposing it to matching sets of primary and secondary structures from a database, was used to analyze the human immunodeficiency virus (HIV) proteins p17, gp120, and gp41 from their amino acid sequences. The results are compared to those obtained by the Chou-Fasman analysis. Two alpha-helical sequences corresponding to the putative fusigenic domain and to the transmembrane domain of gp41 could be predicted, as well as a possible binding site between p17 and gp41. On the basis of the secondary structure predictions, a three-dimensional model of p17 was constructed. This model was found to represent a stable conformation by an analysis using an energy-minimization program. The model predicts that p17 is attached to the membrane only by the acylated N-terminus, in analogy with the N-terminus of the gag protein of other retroviruses and also with the src oncogene protein p60src. The intracellular C-terminal part of gp41 may act as a receptor by electrostatic interaction with p17.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Amino Acid Sequence
  • Computer Simulation*
  • Gene Products, env / analysis
  • Gene Products, gag*
  • HIV Antigens*
  • HIV Envelope Protein gp120*
  • HIV Envelope Protein gp160
  • HIV Envelope Protein gp41*
  • HIV-1 / analysis*
  • Models, Molecular
  • Molecular Sequence Data
  • Protein Conformation
  • Protein Precursors / analysis
  • Software
  • Viral Proteins*
  • gag Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, env
  • Gene Products, gag
  • HIV Antigens
  • HIV Envelope Protein gp120
  • HIV Envelope Protein gp160
  • HIV Envelope Protein gp41
  • Protein Precursors
  • Viral Proteins
  • gag Gene Products, Human Immunodeficiency Virus
  • p17 protein, Human Immunodeficiency Virus Type 1